Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Safety cohort data from phase II study of prexigebersen plus frontline therapies for AML

April 6, 2021

Yingli reports phase II topline data on linperlisib in relapsed or refractory follicular lymphoma

April 1, 2021

China's NMPA approves Ayvakit for GIST with PDGFRA exon 18 mutation

April 1, 2021

Qinlock approved in China for advanced GIST

April 1, 2021

COMMD1 as therapeutic target and diagnostic biomarker in NSCLC

April 1, 2021

Sichuan Kelun-Biotech Biopharmaceutical patents nuclear receptor ROR-gamma agonists

April 1, 2021

New Nur77 receptor ligands disclosed by Ixmedicine

April 1, 2021

IMPACT Therapeutics identifies new ATM kinase inhibitors

April 1, 2021

Disulfiram blocks conformational changes of the complex between human p97 and its cofactor Npl4/Ufd1

March 31, 2021

Cabometyx with Opdivo approved in E.U. for first-line advanced RCC

March 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...